Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells

Study ID:	37053
Short Title:	Celgene LTFU to JCAR017 - 0451-0266
Trust Name:	UHS
Recruitment Site:	Southampton General Hospital
Disease Area:	Haematology
Phase:	II
Expected End Date:	04/03/2025
Postcode:	SO16 6YD
Contact Name:	Amanda Pattie
Contact Email:	studysupport1and3.crnwessex@nihr.ac.uk
Active:	Yes

Patients who received at least one dose of JCAR017 in a previous treatment protocol, and have discontinued, or completed the post-treatment follow-up period in a previous JCAR017 protocol, as applicable.

There are no exclusion criteria.

Study Map List of studies

Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells

Inclusion criteria, exclusion criteria and study summary

Inclusion Criteria

Exclusion Criteria

Study summary

Your Feedback

Accessibility tools